Twist Bioscience Corp TWST

Morningstar Rating
$112.05 +6.90 (6.56%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TWST is trading at a LOCK|>ddX& premium.
Price
$105.04
Fair Value
LOCK|>.%HzJ>><%
Uncertainty
LOCK|Pj
1-Star Price
LOCK|K.!??#Wp%
5-Star Price
LOCK|.^&kPKH
Economic Moat
LOCK|%@%
Capital Allocation
—

News

Trading Information

Previous Close Price
$105.04
Day Range
$102.83–112.19
52-Week Range
$24.44–219.22
Bid/Ask
$85.76 / $144.28
Shares Outstanding
68.18M
Market Cap
$7.33B
Volume/Avg
1M / 2M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
15.21
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Twist Bioscience Corp provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. The core of its business is a proprietary platform that allows it to manufacture synthetic DNA by writing DNA on a silicon chip. The company operates as one reportable and operating segment, through which it develops, manufactures and sells DNA Synthesis and Protein Solutions and NGS Applications products and services. It has presence in Americas, EMEA, and APAC. Majority of revenue comes from Americas. Its products are Genes, Oligo Pools, NGS, Variant Libraries, Synthetic Controls, Antibody Discovery, and VDR Solutions.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
979

Valuation

Metric
TWST
Price/Earnings (Normalized)
—
Price/Book Value
8.33
Price/Sales
15.21
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
TWST
Quick Ratio
5.37
Current Ratio
5.86
Interest Coverage
—
Quick Ratio
TWST

Profitability

Metric
TWST
Return on Assets (Normalized)
−9.71%
Return on Equity (Normalized)
−13.40%
Return on Invested Capital (Normalized)
−12.50%
Return on Assets
TWST

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|>DjpMNLOCK|%#XpZ$136B
Regeneron Pharmaceuticals Inc
REGN
LOCK|%>pdc?NLOCK|>WG<!$99B
Moderna Inc
MRNA
LOCK|jTpntCKLOCK|%mj$87B
argenx SE ADR
ARGX
LOCK|V!gKGJJLOCK|b@$61B
BeOne Medicines Ltd ADR
ONC
LOCK|#QT^WC!LOCK|&<$48B
Royalty Pharma PLC Class A
RPRX
LOCK|>N&rZZ?!LOCK|kM<z$31B
Incyte Corp
INCY
LOCK|MpZQksLOCK|m@$25B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|<S!?>PLOCK|<Nw@S$21B
BioNTech SE ADR
BNTX
LOCK|>m^S%S&LOCK|GY$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|%Y>^M?LOCK|mJ$15B

Sponsor Center